Press Release: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 March 2014

The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) gave recommendations on three safety referrals at its March 2014 meeting.

• Primary Source

ESO: Background information: Press Release: PRAC re-examines diacerein and recommends that it remain available with restrictions http://www.europeansources.info/record/press-release-prac-re-examines-diacerein-and-recommends-that-it-remain-available-with-restrictions/

ESO: Background information: Press Release: PRAC recommends restricting use of domperidone http://www.europeansources.info/record/press-release-prac-recommends-restricting-use-of-domperidone/

ESO: Background information: Press Release: PRAC recommends product information of zolpidem be updated with new advice to minimise the risk of next-morning impaired driving ability and mental alertness http://www.europeansources.info/record/press-release-prac-recommends-product-information-of-zolpidem-be-updated-with-new-advice-to-minimise-the-risk-of-next-morning-impaired-driving-ability-and-mental-alertness/

---